Loading...
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...
Na minha lista:
| Udgivet i: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310345/ https://ncbi.nlm.nih.gov/pubmed/34208884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070708 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|